NEW YORK -- Pharmaceutical startup Insilico Medicine has begun Phase 2 clinical trials of the world's first drug candidate of its kind to be discovered and designed using generative artificial intelligence.
Pharmaceuticals
Fosun-backed startup begins human trials of AI-designed lung drug
Insilico Medicine taps emerging tech in quest to treat pulmonary fibrosis
Insilico Medicine has identified 12 drug candidates since 2021 with the help of AI, including for liver and breast cancer. (Photo courtesy of the company)
Read Next
%2520%E3%81%AE%E3%82%B3%E3%83%94%E3%83%BC.jpg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
Latest on Pharmaceuticals
